Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Subcuject is a private Danish medtech company developing proprietary subcutaneous drug-delivery devices rather than therapeutics. Its core products are a wearable bolus injector and a hands-free autoinjector designed for patient-friendly administration of biologics and other high-volume or high-viscosity injectable drugs in home settings. The platform uses an osmosis-based drive mechanism and low-complexity mechanical design to avoid electronics while enabling configurable delivery volumes from below 1 mL to above 10 mL. Subcuject appears to operate primarily as a platform and partnering company for pharma and device manufacturers, including collaboration on development and manufacturing for combination products. The company has emphasized usability for patients with dexterity limitations and integration with standard pharmaceutical cartridges and filling workflows.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Subcuject.